drugset / Trial / NCT01090713
Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
Phase 3
Completed
50 enrolled
Lindner Center of HOPE
Shire · collabUniversity of Cincinnati · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder
Timeline
- Start
- 2010-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lisdexamfetamine | Other / unclassified | 20 mg | Oral |
| Comparator | Lisdexamfetamine | Other / unclassified | 70 mg | Oral |